Lucintel Forecasts Oligonucleotide Synthesis Market To Grow At A Cagr Of 10%-12%

By Author: Lucintel LLC
Total Articles: 6457
Comment this article

According to the recent study the oligonucleotide synthesis market is projected to grow at a CAGR of 10%-12% from 2020 to 2026. Growth in this market is primarily driven by rising research activities in synthetic biology, increasing prevalence of cancer & infectious diseases, and growing demand for innovative and therapeutic techniques.
Browse XX figures / charts and XX tables in this 150-page report to understand trends, opportunities and forecast in oligonucleotide synthesis market by offering (synthesized oligonucleotides (products (oligonucleotide-based drugs, primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors), services (custom oligonucleotides and pre-designed oligonucleotides), reagents & consumables, and equipment), application (research (PCR, qPCR, sequencing, gene synthesis, and other research applications), diagnostics, therapeutics (DNA & antisense oligonucleotide-based therapies, RNAi oligonucleotide-based therapies, and CPG oligonucleotide-based therapies)), end user (academic & research institutes, pharmaceutical ...
... & biotechnology companies, diagnostic laboratories, and hospitals), and region (North America, Europe, Asia Pacific, and Rest of the World).
Download sample report and view detailed Table of Content by clicking on below link https://www.lucintel.com/oligonucleotide-synthesis-market.aspx
“Synthesized oligonucleotides market is expected to remain the largest segment during the forecast period.”
Based on offering, the oligonucleotide synthesis market is segmented into synthesized oligonucleotides (products (oligonucleotide-based drugs, primers, probes, large-scale synthesis oligonucleotides, intermediate-scale synthesis oligonucleotides, and linkers & adaptors), services (custom oligonucleotides and pre-designed oligonucleotides), reagents & consumables, and equipment). Lucintel forecasts that the synthesized oligonucleotides market is expected to remain the largest segment during the forecast period due to rising research and development activities related to oligonucleotide-based drugs.
“Within the oligonucleotide synthesis market, the supplements segment is expected to remain the largest end user”
Based on end user, the hospitals segment is expected to witness the largest segment over the forecast period due to a significant number of inpatient and outpatient visits and increasing prevalence of cancer and infectious diseases.

“North America will dominate the oligonucleotide synthesis market in near future”
North America is expected to be the largest region over the forecast period due to rising research and development activities related to life science and the increasing number of oligonucleotide-based drugs/therapies being approved by the FDA (Food and Drug Administration) in the region.
Download Brochure of this report by clicking on https://www.lucintel.com/oligonucleotide-synthesis-market.aspx
Major players of oligonucleotide synthesis market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. General Electric, Merck, Eurofins Scientific, Agilent Technologies, LGC Biosearch Technologies, Integrated DNA Technologies, GeneDesign, Nitto Denko Avecia, Trilink Biotechnologies, and Kaneka Eurogentec are among the major oligonucleotide synthesis providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/oligonucleotide-synthesis-market.aspx or helpdesk@lucintel.com
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times. For further information, visit www.lucintel.com

Contact:
Brandon Fitzgerald
Lucintel
Dallas, Texas, USA
Email: brandon.fitzgerald@lucintel.com
Tel. 972.636.5056
Cell: 303.775.0751

Related reports
Surgical Instrument Tracking System Market:
For more details click here https://www.lucintel.com/surgical-instrument-tracking-system-market.aspx

Metabolomics Market:
For more details click here https://www.lucintel.com/metabolomics-market.aspx

Industrial Microbiology Market:
For more details click here https://www.lucintel.com/industrial-microbiology-market.aspx

Surgical Microscope Market:
For more details click here https://www.lucintel.com/surgical-microscope-market.aspx

Tumor Ablation Market:
For more details click here https://www.lucintel.com/tumor-ablation-market.aspx

Vitamin D Market:
For more details click here https://www.lucintel.com/vitamin-d-market.aspx

Urology Device Market:
For more details click here https://www.lucintel.com/urology-device-market.aspx

Halal Ingredient Market:
For more details click here https://www.lucintel.com/halal-ingredient-market.aspx

Gene Expression Market:
For more details click here https://www.lucintel.com/gene-expression-market.aspx

GMO Testing Market:
For more details click here https://www.lucintel.com/gmo-testing-market.aspx